1. Home
  2. SXI vs XENE Comparison

SXI vs XENE Comparison

Compare SXI & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standex International Corporation

SXI

Standex International Corporation

N/A

Current Price

$259.76

Market Cap

3.1B

Sector

Industrials

ML Signal

N/A

XENE

Xenon Pharmaceuticals Inc.

N/A

Current Price

$53.40

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SXI
XENE
Founded
1955
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.2B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
SXI
XENE
Price
$259.76
$53.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$281.33
$67.17
AVG Volume (30 Days)
150.5K
1.7M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
0.54%
N/A
EPS Growth
N/A
N/A
EPS
1.42
N/A
Revenue
$604,535,000.00
$311,000.00
Revenue This Year
$15.98
N/A
Revenue Next Year
$8.09
$2,823.63
P/E Ratio
$176.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$128.85
$26.74
52 Week High
$270.87
$62.91

Technical Indicators

Market Signals
Indicator
SXI
XENE
Relative Strength Index (RSI) 53.76 58.07
Support Level $243.25 $38.36
Resistance Level $267.47 $62.91
Average True Range (ATR) 10.26 2.15
MACD -0.64 -0.17
Stochastic Oscillator 61.20 56.44

Price Performance

Historical Comparison
SXI
XENE

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: